Nimorazole

Nimorazole (INN) is a nitroimidazole anti-infective.[1] It is also being investigated for the treatment of head and neck cancer.[2][3]

Nimorazole
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.026.723
Chemical and physical data
FormulaC9H14N4O3
Molar mass226.23 g/mol g·mol−1
3D model (JSmol)
  (verify)

References
  1. Roy, R. B.; Laird, S. M.; Heasman, L. (1975). "Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole". The British Journal of Venereal Diseases. 51 (4): 281–284. PMC 1046566. PMID 1098732.
  2. Henk, J. M.; Bishop, K.; Shepherd, S. F. (2003). "Treatment of head and neck cancer with CHART and nimorazole: Phase II study". Radiotherapy and Oncology. 66 (1): 65–70. doi:10.1016/S0167-8140(02)00284-0. PMID 12559522.
  3. Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.